COL-3
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for COL-3, covering 2008-03-04 to 2013-06-21. Get the full timeline:
Most recent: Clinical Trial Update: COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors [Phase 1, Phase 2]